PTAFR and neoplasm: To compare the levels of PAF-R agonists generated between intratumoral chemotherapy and IR, we subjected mice previously implanted with two B16F10 tumors to intratumoral injections of etoposide (36mg/kg) or melphalan (15mg/kg) to one tumor with the other tumor treated with 50 μl of saline vehicle [24].